McFadden G - Search Results

1

Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.

Zemp FJ, McKenzie BA, Lun X, Reilly KM, McFadden G, Yong VW, Forsyth PA. Zemp FJ, et al. Among authors: mcfadden g. Cancer Res. 2014 Dec 15;74(24):7260-73. doi: 10.1158/0008-5472.CAN-14-0876. Epub 2014 Oct 21. Cancer Res. 2014. PMID: 25336188 Free PMC article.

2

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.

Lun X, Yang W, Alain T, Shi ZQ, Muzik H, Barrett JW, McFadden G, Bell J, Hamilton MG, Senger DL, Forsyth PA. Lun X, et al. Among authors: mcfadden g. Cancer Res. 2005 Nov 1;65(21):9982-9990. doi: 10.1158/0008-5472.CAN-05-1201. Cancer Res. 2005. PMID: 16267023 Free PMC article.

3

Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.

Lun XQ, Zhou H, Alain T, Sun B, Wang L, Barrett JW, Stanford MM, McFadden G, Bell J, Senger DL, Forsyth PA. Lun XQ, et al. Among authors: mcfadden g. Cancer Res. 2007 Sep 15;67(18):8818-27. doi: 10.1158/0008-5472.CAN-07-1214. Cancer Res. 2007. PMID: 17875723 Free PMC article.

4

The role of cell signaling in poxvirus tropism: the case of the M-T5 host range protein of myxoma virus.

Werden SJ, McFadden G. Werden SJ, et al. Among authors: mcfadden g. Biochim Biophys Acta. 2008 Jan;1784(1):228-37. doi: 10.1016/j.bbapap.2007.08.001. Epub 2007 Aug 14. Biochim Biophys Acta. 2008. PMID: 17905673 Review.

5

Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.

Barrett JW, Alston LR, Wang F, Stanford MM, Gilbert PA, Gao X, Jimenez J, Villeneuve D, Forsyth P, McFadden G. Barrett JW, et al. Among authors: mcfadden g. J Neurovirol. 2007 Dec;13(6):549-60. doi: 10.1080/13550280701591526. J Neurovirol. 2007. PMID: 18097886

6

Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes?

Stanford MM, Breitbach CJ, Bell JC, McFadden G. Stanford MM, et al. Among authors: mcfadden g. Curr Opin Mol Ther. 2008 Feb;10(1):32-7. Curr Opin Mol Ther. 2008. PMID: 18228179 Review.

7

Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.

Wu Y, Lun X, Zhou H, Wang L, Sun B, Bell JC, Barrett JW, McFadden G, Biegel JA, Senger DL, Forsyth PA. Wu Y, et al. Among authors: mcfadden g. Clin Cancer Res. 2008 Feb 15;14(4):1218-27. doi: 10.1158/1078-0432.CCR-07-1330. Clin Cancer Res. 2008. PMID: 18281557 Free PMC article.

8

Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200).

Zhang L, Stanford M, Liu J, Barrett C, Jiang L, Barclay AN, McFadden G. Zhang L, et al. Among authors: mcfadden g. J Virol. 2009 Sep;83(18):9602-7. doi: 10.1128/JVI.01078-09. Epub 2009 Jul 1. J Virol. 2009. PMID: 19570854 Free PMC article.

9

Co-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013.

Rahman MM, Mohamed MR, Kim M, Smallwood S, McFadden G. Rahman MM, et al. Among authors: mcfadden g. PLoS Pathog. 2009 Oct;5(10):e1000635. doi: 10.1371/journal.ppat.1000635. Epub 2009 Oct 23. PLoS Pathog. 2009. PMID: 19851467 Free PMC article.

10

Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.

Lun X, Alain T, Zemp FJ, Zhou H, Rahman MM, Hamilton MG, McFadden G, Bell J, Senger DL, Forsyth PA. Lun X, et al. Among authors: mcfadden g. Cancer Res. 2010 Jan 15;70(2):598-608. doi: 10.1158/0008-5472.CAN-09-1510. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

629 results

Search Page

Filters